200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 525-72-4

525-72-4

525-72-4 | 1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol

CAS No: 525-72-4 Catalog No: AG00DJPN MDL No:MFCD00056097

Product Description

Catalog Number:
AG00DJPN
Chemical Name:
1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol
CAS Number:
525-72-4
Molecular Formula:
C10H13NO2
Molecular Weight:
179.2157
MDL Number:
MFCD00056097
IUPAC Name:
1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol
InChI:
InChI=1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3
InChI Key:
IBRKLUSXDYATLG-UHFFFAOYSA-N
SMILES:
CC1NCCc2c1cc(O)c(c2)O

Properties

Complexity:
186  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
179.095g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
179.219g/mol
Monoisotopic Mass:
179.095g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
52.5A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
1  

Literature

Title Journal
Oxidative DNA damage and mammary cell proliferation by alcohol-derived salsolinol. Chemical research in toxicology 20131021
Salsolinol induced apoptotic changes in neural stem cells: amelioration by neurotrophin support. Neurotoxicology 20130301
What is in that drink: the biological actions of ethanol, acetaldehyde, and salsolinol. Current topics in behavioral neurosciences 20130101
Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line. Neurotoxicology 20120601
Effects of photoperiod on salsolinol-induced prolactin secretion in goats. Animal science journal = Nihon chikusan Gakkaiho 20120501
Salsolinol and isosalsolinol: condensation products of acetaldehyde and dopamine. Separation of their enantiomers in the presence of a large excess of dopamine. Journal of pharmaceutical and biomedical analysis 20120407
Salsolinol stimulates dopamine neurons in slices of posterior ventral tegmental area indirectly by activating μ-opioid receptors. The Journal of pharmacology and experimental therapeutics 20120401
Hypotensive and cardio-chronotropic constituents of Tinospora crispa and mechanisms of action on the cardiovascular system in anesthetized rats. Journal of ethnopharmacology 20120306
Salsolinol, a tetrahydroisoquinoline-derived neurotoxin, induces oxidative modification of neurofilament-L protection by histidyl dipeptides. BMB reports 20120201
Revisiting the controversial role of salsolinol in the neurobiological effects of ethanol: old and new vistas. Neuroscience and biobehavioral reviews 20120101
Bromocriptine inhibits salsolinol-induced prolactin release in male goats. Animal science journal = Nihon chikusan Gakkaiho 20120101
Salsolinol facilitates glutamatergic transmission to dopamine neurons in the posterior ventral tegmental area of rats. PloS one 20120101
Research on an in vitro cell system for testing the neurotoxicity of kynurenine pathway metabolites. Die Pharmazie 20111101
Induction of conditioned place preference and dopamine release by salsolinol in posterior VTA of rats: involvement of μ-opioid receptors. Neurochemistry international 20111001
Chip electrophoresis of active banana ingredients with label-free detection utilizing deep UV native fluorescence and mass spectrometry. Analytical and bioanalytical chemistry 20110201
Isolation of salsolinol, a tetrahydroisoquinoline alkaloid, from the marine sponge Xestospongia cf. vansoesti as a proteasome inhibitor. Chemical & pharmaceutical bulletin 20110101
The influence of salsolinol on dopaminergic system activity within the mediobasal hypothalamus of anestrous sheep: a model for studies on the salsolinol-dopamine relationship. Acta neurobiologiae experimentalis 20110101
The effects of salsolinol on the mucosal mast cells in the rat gut. Folia medica Cracoviensia 20110101
Opioid-salsolinol relationship in the control of prolactin release during lactation. Neuroscience 20101110
Characteristics of prolactin-releasing response to salsolinol in vivo in cattle. Domestic animal endocrinology 20100701
Determination of salsolinol, norsalsolinol, and twenty-one biogenic amines using micellar electrokinetic capillary chromatography-electrochemical detection. Electrophoresis 20100601
Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats: role of mu-opioid receptors. Psychopharmacology 20100301
A critical evaluation of influence of ethanol and diet on salsolinol enantiomers in humans and rats. Alcoholism, clinical and experimental research 20100201
Effects of a structural analogue of salsolinol, 1-MeDIQ, on pituitary prolactin release and dopaminergic activity in the mediobasal hypothalamus in nursing sheep. Brain research 20100111
Effects of salsolinol and its antagonistic analogue, 1-MeDIQ, on growth hormone release in nursing sheep. Acta neurobiologiae experimentalis 20100101
Different mechanisms of NMDA-mediated protection against neuronal apoptosis: a stimuli-dependent effect. Neurochemical research 20091101
Local salsolinol modulates dopamine extracellular levels from rat nucleus accumbens: shell/core differences. Neurochemistry international 20090901
Ferritin enhances salsolinol-mediated DNA strand breakage: protection by carnosine and related compounds. Toxicology letters 20090710
Fast liquid chromatography separation and multiple-reaction monitoring mass spectrometric detection of neurotransmitters. Journal of separation science 20090701
Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants. Domestic animal endocrinology 20090201
Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection. Rapid communications in mass spectrometry : RCM 20081201
The formation of catechol isoquinolines in PC12 cells exposed to manganese. Neuroscience letters 20081024
Identification of salsolinol in the mediobasal hypothalamus of lactating ewes and its relation to suckling-induced prolactin and GH release. The Journal of endocrinology 20080701
Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation. Thrombosis and haemostasis 20080701
Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neuroscience bulletin 20080601
Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants. Domestic animal endocrinology 20080401
Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease. Clinical chemistry 20080401
Quantitative chiral analysis of salsolinol in different brain regions of rats genetically predisposed to alcoholism. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080301
Salsolinol is present in the bovine posterior pituitary gland and stimulates the release of prolactin both in vivo and in vitro in ruminants. Domestic animal endocrinology 20080201
The reinforcing properties of salsolinol in the ventral tegmental area: evidence for regional heterogeneity and the involvement of serotonin and dopamine. Alcoholism, clinical and experimental research 20080201
The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochemistry international 20080101
Simultaneous determination of salsolinol enantiomers and dopamine in human plasma and cerebrospinal fluid by chemical derivatization coupled to chiral liquid chromatography/electrospray ionization-tandem mass spectrometry. Analytical chemistry 20071201
The role of catecholamines in the prolactin release induced by salsolinol. Neurochemistry international 20071001
Salsolinol, a tetrahydroisoquinoline catechol neurotoxin, induces human Cu,Zn-superoxidie dismutase modificaiton. Journal of biochemistry and molecular biology 20070930
Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotoxicity research 20070701
Salsolinol and the peripheral sympathetic activity: the effects of hypophysectomy, adrenalectomy and adrenal medullectomy. Ideggyogyaszati szemle 20070330
Effect of direct infusion of acetaldehyde on dopamine and dopamine-derived salsolinol in the striatum of free-moving rats using a reverse microdialysis technique. Archives of toxicology 20070201
The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin. Neurochemistry international 20070101
TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis. Brain research 20060712
Determination of salsolinol and related catecholamines through on-line preconcentration and liquid chromatography/atmospheric pressure photoionization mass spectrometry. Analytical chemistry 20060515
Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiological research 20060101
Chronic polysystemic candidiasis as a possible contributor to onset of idiopathic Parkinson's disease. Bratislavske lekarske listy 20060101
Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease. Neurotoxicity research 20051101
Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics. Alcoholism, clinical and experimental research 20050101
Salsolinol, an antagonist of prolactoliberine, induces an increase in plasma catecholamine levels in the rat. Autonomic neuroscience : basic & clinical 20040930
Immobilization stress-induced increase in plasma catecholamine levels is inhibited by a prolactoliberin (salsolinol) administration. Annals of the New York Academy of Sciences 20040601
Pivotal role of an endogenous tetrahydroisoquinoline, salsolinol, in stress- and suckling-induced release of prolactin. Annals of the New York Academy of Sciences 20040601
Bioconversion studies in cultured cells of Corydalis species. Die Pharmazie 20040601
Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein. Brain research 20040416
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 20040401
Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. The Analyst 20040301
Stress- as well as suckling-induced prolactin release is blocked by a structural analogue of the putative hypophysiotrophic prolactin-releasing factor, salsolinol. Journal of neuroendocrinology 20040301
Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains. Neurotoxicology 20040101
Inhibition of DT-diaphorase potentiates the in vivo neurotoxic effect of intranigral injection of salsolinol in rats. Neurotoxicity research 20040101
[Change of dopamine, serotonin and opioid neuromediator systems in the brain of rats adapted to prolonged effect of ethanol]. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20040101
Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds. Bioorganic & medicinal chemistry letters 20030901
In vivo study of salsolinol produced by a high concentration of acetaldehyde in the striatum and nucleus accumbens of free-moving rats. Alcoholism, clinical and experimental research 20030801
Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective. Cellular and molecular biology (Noisy-le-Grand, France) 20030701
Tyrosinase protects human melanocytes from ROS-generating compounds. Biochemical and biophysical research communications 20030530
Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity. Neuroscience letters 20030410
Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P) rats. Alcoholism, clinical and experimental research 20030301
Effect of different doses of cyanamide on striatal salsolinol formation after ethanol treatment. Legal medicine (Tokyo, Japan) 20030301
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat. Neurochemistry international 20030101
['Starburst' conjugates of proteins with carbocene polymers, carrying low molecular weight biologically-active compounds, and their immunogenicity]. Bioorganicheskaia khimiia 20030101
In vivo formation of salsolinol induced by high acetaldehyde concentration in rat striatum employing microdialysis. Alcohol and alcoholism (Oxford, Oxfordshire) 20030101
Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotoxicity research 20030101
Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells. Neuro-Signals 20030101
Assay of salsolinol in peripheral blood mononuclear cells of alcoholics and healthy subjects by gas chromatography-mass spectrometry. Addiction biology 20021001
Formation of novel toxic compounds from oxidative interaction between salsolinol and cysteine. Journal of pharmaceutical and biomedical analysis 20020905
Iron enhancement of oxidative DNA damage and neuronal cell death induced by salsolinol. Journal of toxicology and environmental health. Part A 20020301
Resistance of the insect cell line IPLB-LdFB to salsolinol-induced apoptosis. Archives of insect biochemistry and physiology 20020101
Physiological role of salsolinol: its hypophysiotrophic function in the regulation of pituitary prolactin secretion. Neurotoxicology and teratology 20020101
Salsolinol is a putative endogenous neuro-intermediate lobe prolactin-releasing factor. Journal of neuroendocrinology 20011201
Simple isoquinoline and benzylisoquinoline alkaloids as potential antimicrobial, antimalarial, cytotoxic, and anti-HIV agents. Bioorganic & medicinal chemistry 20011101
Differential cell death induced by salsolinol with and without copper: possible role of reactive oxygen species. Molecular pharmacology 20010901
Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free radical biology & medicine 20010615
Possible role of salsolinol quinone methide in the decrease of RCSN-3 cell survival. Biochemical and biophysical research communications 20010525
Purification and characterization of coclaurine N-methyltransferase from cultured Coptis japonica cells. Phytochemistry 20010401
Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, induces DNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells. Mutation research 20010301
Biphasic effects of acetaldehyde-biogenic amine condensation products on membrane fluidity. The Journal of pharmacy and pharmacology 20010101
Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice. Journal of neural transmission (Vienna, Austria : 1996) 20010101

© 2019 Angene International Limited. All rights Reserved.